Veranova Invests US$50 Million to Expand ADC Manufacturing Facility in Massachusetts, USA
Introduction:
Veranova plans to invest over US$50 million to expand its manufacturing facility in Devens, Massachusetts, USA.
Features:
The expansion includes an additional 9,000 square feet at the Devens facility.
A new process development laboratory and two cGMP manufacturing suites will be constructed as part of the project.
The facility will support the development and production of potent compounds, ADC linker-payloads, and other complex pharmaceutical substances.
Infrastructure will be designed to accommodate safe handling of highly potent materials, with containment systems aligned with regulatory requirements.
The expansion will enable bioconjugation development and cGMP manufacturing within the same site.
Laboratory and manufacturing areas will be equipped for clinical and small-scale commercial production.
Monitoring systems and digital infrastructure will be incorporated to support quality control and compliance.
The site is located near the Boston life sciences cluster, providing access to regional supply chains and workforce.
Specifications:
| Name | Veranova |
| Type | New Construction |
| Budget | US$50 million |
